Galmed Pharmaceuticals
GLMD
#10426
Rank
โ‚น0.51 B
Marketcap
โ‚น93.14
Share price
-2.83%
Change (1 day)
-61.89%
Change (1 year)

Revenue for Galmed Pharmaceuticals (GLMD)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Galmed Pharmaceuticals from 2013 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A-100%
2018 โ‚น0.14 B105.7%
2017 โ‚น69.27 M118.3%
2016 โ‚น31.73 M
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Catalent
CTLT
โ‚น399.84 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
โ‚น181.88 BN/A๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
โ‚น19.34 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Evoke Pharma
EVOK
โ‚น1.15 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA